Celldex Therapeutics (CLDX) Current Leases (2019 - 2025)
Historic Current Leases for Celldex Therapeutics (CLDX) over the last 7 years, with Q3 2025 value amounting to $1.6 million.
- Celldex Therapeutics' Current Leases rose 1261.78% to $1.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.6 million, marking a year-over-year increase of 1261.78%. This contributed to the annual value of $1.5 million for FY2024, which is 1003.72% down from last year.
- Celldex Therapeutics' Current Leases amounted to $1.6 million in Q3 2025, which was up 1261.78% from $1.5 million recorded in Q2 2025.
- Celldex Therapeutics' Current Leases' 5-year high stood at $1.8 million during Q1 2022, with a 5-year trough of $1.3 million in Q2 2021.
- In the last 5 years, Celldex Therapeutics' Current Leases had a median value of $1.5 million in 2025 and averaged $1.5 million.
- Examining YoY changes over the last 5 years, Celldex Therapeutics' Current Leases showed a top increase of 3157.5% in 2021 and a maximum decrease of 1843.04% in 2021.
- Celldex Therapeutics' Current Leases (Quarter) stood at $1.7 million in 2021, then fell by 17.24% to $1.4 million in 2022, then increased by 11.7% to $1.6 million in 2023, then dropped by 10.04% to $1.5 million in 2024, then increased by 6.96% to $1.6 million in 2025.
- Its Current Leases was $1.6 million in Q3 2025, compared to $1.5 million in Q2 2025 and $1.5 million in Q1 2025.